This is a working overview of GABA-A receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-07-11 and is reviewed periodically as new material appears.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.
Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.
The primary structure of Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, corresponding to the molecular formula C33H57N11O9 and a monoisotopic mass of roughly 751.9 daltons. The N-terminal threonine and the arginine residue in the fourth position are shared with tuftsin, which carries the sequence Thr-Lys-Pro-Arg. The three additional residues at the C-terminus, Pro-Gly-Pro, extend the chain and are associated with greater resistance to enzymatic degradation. This extension also separates Selank from the shorter parent peptide.
Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C33H57N11O9 | Free peptide form |
| Molecular mass | About 751.9 Da | Calculated average mass |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Single-letter form TKPRPGP |
| Structural basis | Tuftsin analogue | Extended version of a natural tetrapeptide |
| Development origin | Russian Academy of Sciences | Work carried out from the 1980s onward |
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
Proposed mechanisms center on modulation of the GABA system, but no single molecular target has been confirmed. Rodent studies report changes in GABA-A receptor expression and in the turnover of serotonin, dopamine, and norepinephrine in several brain regions. Increases in brain-derived neurotrophic factor and its receptor have also been described after repeated administration. These findings come largely from animal models, and the degree to which they describe human neurochemistry remains an open question. The mechanism is best characterized as multi-system and not fully resolved.
Quantification in biological matrices relies on liquid chromatography coupled to tandem mass spectrometry with stable-isotope internal standards. Low plasma concentrations and adsorption to container surfaces both complicate measurement. Solid-phase extraction is often needed to reduce matrix interference before injection. Reported limits of quantification differ widely between laboratories, which makes direct comparison of pharmacokinetic results difficult and limits meta-analysis.
Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.
Lyophilised material kept dry at minus 20 degrees Celsius or colder is the most stable form, and suppliers commonly state a shelf life of two years or more under those conditions. Once dissolved, degradation accelerates through hydrolysis and deamidation, particularly at alkaline pH or elevated temperature. Working solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. The choice of reconstitution solvent affects both stability and the ionic strength of the final preparation.
Reversed-phase high-performance liquid chromatography is the standard technique for estimating peptide purity. The result is a peak-area percentage, which describes how much of the detected material elutes as the main peak in one run. Mass spectrometry confirms the molecular mass and can reveal truncated, adducted, or otherwise modified species. Amino acid analysis or tandem mass spectrometry can address sequence fidelity when identity is in doubt. None of these measurements, taken alone, establishes that a sample is fit for any specific purpose.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
Proteins can be engineered to improve the chance of successful protein crystallization. A common way is by trimming the recombinant construct to remove N- and C- terminal parts, which are frequently disordered or poorly structured ("high entropy"). Surface entropy reduction entails replacing surface residue clusters with high conformational entropy (usually lysine, glutamate, and glutamine) with alanines. In a similar vein, replacing lysine with arginine in bulk has proven useful. It is also possible to engineer in crystal contacts by mutating residues. An even more advanced method involves the use of "chaperone" proteins known to be more crystallizable. This can be achieved by designing a fusion protein consisting of the protein with unknown structure and a protein domain known to crystalize well. The interaction in question can also be intermolecular, for example between the candidate protein and some antibody Fab fragments selected to bind tightly to the protein, or between a candidate-maltose-binding protein (MBP) fusion and a protein specifically designed to bind MBP. Many methods for protein engineering require some forward knowledge of protein structure, either simply knowing what residues are surface or buried or knowing the full tertiary structure. Modern protein structure prediction tools are largely sufficient. It is also possible to predict the result of crystallization using these methods. Cystine residues on the surface tend to cause trouble for recombinant protein production by causing aggregation. They can be replaced with alanines.
== History == The black mamba (Dendroaspis polylepis) is generally considered to be one of the deadliest snakes on the planet, and is responsible for many fatalities throughout its sub-Saharan Africa range. Without treatment, the bite of a black mamba causes a 100% mortality rate. The venom of the black mamba consists of more than 28 peptides. One of these peptides is calciseptine, which makes up 2.8% of the venom. When first purified, the peptide was called protein E3, which was later changed to calciseptine by Weille et al.
=== Utah === On March 13, 2024, Utah Governor Spencer Cox signed the Artificial Intelligence Policy Act (S.B 149). This legislation went into effect on May 1, 2024. It established liability, notably for companies that do not disclose their use of generative AI when required by state consumer protection laws, or when users commit criminal offense using generative AI. It also created the Office of Artificial Intelligence Policy and the Artificial Intelligence Learning Laboratory Program.
Sources: en.wikipedia.org
Aspirin Ibuprofen (Advil, Nurofen) Naproxen (Aleve) There are several potential pharmacokinetic interactions between the various individual SSRIs and other medications. Most of these arise from the fact that every SSRI can inhibit certain P450 cytochrome enzymes.
Peukert wrote that "inner emigration" led to "...self-absorption and self-sufficiency, to the mixture of "apathy and pleasure-seeking" described by one wartime diarist...Paradoxically, then, even the population's counter-reaction to the National Socialist pressure of mobilization served to stabilize the system". Using a phrase coined by the British historian Sir Ian Kershaw, Peukert argued that the "Hitler myth" of a brilliant, infallible, and larger-than-life Führer-a charismatic statesman who was also a talented general and artist-was the main psychological mechanism that held together popular support and acquiescence in the regime as even many Germans who did not like the Nazis accepted the "Hitler myth". Peukert noted that Hitler's role in standing in many ways above his system, with the standard explanation being that der Führer was so busy with questions of war, art and statecraft that he had to delegate policy in the domestic sphere to his subordinates meant that most Germans did not blame the failures of the Nazi system on Hitler. Peukert noted that instead of blaming Hitler, most Germans held to the hope that if only der Führer would pay attention to domestic policy, then matters would be set right. Peukert argued that many Germans disliked the NSDAP functionaries who assumed such power in their neighborhoods and believed if only their "abuses" were brought to Hitler's attention, he would dismiss them.
C-reactive protein (CRP) Procalcitonin (PCT) Presepsin soluble CD14 soluble CD163 soluble CD206 (mannose receptor) soluble TREM-1 The link between gut microbiota constitution and liver health (Particularly in Cirrhosis) has been well described, however specific biomarkers for prediction of Cirrhosis still requires further research. A 2014 study identified 15 microbial biomarkers from the gut microbiota. These could potentially be used to discriminate patients with liver cirrhosis from healthy individuals.
=== Lasers and optics === A large variety of medical applications (i.e., dermatology, dentistry) utilize erbium ion's 2940 nm emission (see Er:YAG laser), which is highly absorbed in water (absorption coefficient about 12000/cm). Such shallow tissue deposition of laser energy is necessary for laser surgery, and the efficient production of steam for laser enamel ablation in dentistry. Common applications of erbium lasers in dentistry include ceramic cosmetic dentistry and removal of brackets in orthodontic braces; such laser applications have been noted as more time-efficient than performing the same procedures with rotary dental instruments. Erbium-doped optical silica-glass fibers are the active element in erbium-doped fiber amplifiers (EDFAs), which are widely used in optical communications. The same fibers can be used to create fiber lasers. In order to work efficiently, erbium-doped fiber is usually co-doped with glass modifiers/homogenizers, often aluminium or phosphorus. These dopants help prevent clustering of Er ions and transfer the energy more efficiently between excitation light (also known as optical pump) and the signal. Co-doping of optical fiber with Er and Yb is used in high-power Er/Yb fiber lasers. Erbium can also be used in erbium-doped waveguide amplifiers.
Sources: en.wikipedia.org
Rubidium can form Rb6O and Rb9O2 (copper-coloured) upon oxidation in air, while caesium forms an immense variety of oxides, such as the ozonide CsO3 and several brightly coloured suboxides, such as Cs7O (bronze), Cs4O (red-violet), Cs11O3 (violet), Cs3O (dark green), CsO, Cs3O2, as well as Cs7O2. The last of these may be heated under vacuum to generate Cs2O. The alkali metals can also react analogously with the heavier chalcogens (sulfur, selenium, tellurium, and polonium), and all the alkali metal chalcogenides are known (with the exception of francium's). Reaction with an excess of the chalcogen can similarly result in lower chalcogenides, with chalcogen ions containing chains of the chalcogen atoms in question. For example, sodium can react with sulfur to form the sulfide (Na2S) and various polysulfides with the formula Na2Sx (x from 2 to 6), containing the S2−x ions. Due to the basicity of the Se2− and Te2− ions, the alkali metal selenides and tellurides are alkaline in solution; when reacted directly with selenium and tellurium, alkali metal polyselenides and polytellurides are formed along with the selenides and tellurides with the Se2−x and Te2−x ions. They may be obtained directly from the elements in liquid ammonia or when air is not present, and are colourless, water-soluble compounds that air oxidises quickly back to selenium or tellurium. The alkali metal polonides are all ionic compounds containing the Po2− ion; they are very chemically stable and can be produced by direct reaction of the elements at around 300–400 °C.
== Further reading == Adams, Jad (2004) Hideous absinthe: a history of the devil in a bottle, London: I.B. Tauris. ISBN 1860649203 Arnold, Wilfred Niels (June 1989). "Absinthe". Scientific American. 260 (6): 112–117. Bibcode:1989SciAm.260f.112A. doi:10.1038/scientificamerican0689-112. PMID 2658044. S2CID 215053033. Retrieved 18 September 2010. Blumer, D. (2002). "The Illness of Vincent van Gogh". American Journal of Psychiatry. 159 (4): 519–526. doi:10.1176/appi.ajp.159.4.519. PMID 11925286. S2CID 43106568. Conrad, Barnaby (1996). Absinthe: History in a Bottle. San Francisco: Chronicle Books. ISBN 978-0811816502. Crowley, Aleister (1918). "Absinthe: The Green Goddess" (PDF). The International. XII (2). Archived from the original (PDF) on 18 September 2020. Retrieved 5 March 2016. Eadie, MJ (2009). "Absinthe, epileptic seizures and Valentin Magnan". The Journal of the Royal College of Physicians of Edinburgh. 39 (1): 73–78. doi:10.1177/1478271520093901011. PMID 19831287. Guthrie, R. Winston (2010). A Taste for Absinthe. New York: Clarkson Potter. p. 176. ISBN 978-0307587534. Archived from the original on 28 February 2019. Retrieved 26 September 2012. Huisman, M.; Brug, J.; MacKenbach, J. (2007). "Absinthe is its history relevant for current public health?". International Journal of Epidemiology. 36 (4): 738–744. doi:10.1093/ije/dym068. hdl:1765/36056. PMID 17982755. Lachenmeier, Dirk W.; Nathan-Maister, David; Breaux, Theodore A.; Sohnius, Eva-Maria; Schoeberl, Kerstin; Kuballa, Thomas (2008).
Saffron likely originated in Iran, Greece, Mesopotamia, or Kashmir. Harold McGee states that it was domesticated in or near Greece during the Bronze Age. C. sativus is probably a triploid form of Crocus cartwrightianus, which is also known as "wild saffron". Saffron crocus was slowly propagated by humans throughout much of Eurasia and was later brought to parts of North Africa, North America, and Oceania. Several wild species of Crocus similar to the commercial plant are known to have been harvested in recent times for use as saffron. Crocus ancyrensis was used to make saffron in Sivas in Central Turkey, the corms were also eaten. Crocus cartwrightianus was harvested on Andros in the islands of the Cyclades, for medicinal purposes and the stigmas for making a pigment called Zafran. Crocus longiflorus stigmas were used for saffron in Sicily. Crocus thomasii stigmas were used to flavour dishes around Taranto, South Italy. In Syria the stigmas of an unknown wild species were collected by women and children, sun-dried and pressed into small tablets which were sold in the Bazaars. Not all ancient depictions or descriptions of saffron spice or flowers are certain to be the same species as the modern commercial species used for spice.
=== Menu === The menu, which features hot specialty subs, salads, and other seasonal items, takes inspiration from the firehouse with names like Hook & Ladder, Engineer, and Firehouse Hero. The subs are prepared with meats and cheeses, on toasted sub rolls, and served "Fully Involved" with vegetables and condiments. Chris and Robin remain in charge of the menu, and work alongside their director of product development Jay Miller, who joined the company in 2017.
Baylor University sexual assault scandal – in 2016, Baylor and its football program were rocked by the revelation that university officials failed to act on numerous alleged sexual and non-sexual assaults by football team members between 2012 and 2016, with one player convicted of felony sexual assault. A later lawsuit filed by a group of victims alleged that 31 football players committed 52 rapes between 2011 and 2014. In the wake of the scandal, head football coach Art Briles was fired, athletic director Ian McCaw resigned, and university president Ken Starr was first demoted and then resigned. 2017–18 NCAA Division I men's basketball corruption scandal – An ongoing FBI investigation into corruption in NCAA men's basketball that has so far resulted in the arrest of 10 individuals, including college assistant coaches from Arizona, Auburn, Oklahoma State, and USC plus high-ranking executives of sports apparel giant Adidas. Other programs initially implicated in the scandal included Louisville, Miami (FL), and South Carolina. Louisville placed head coach Rick Pitino and athletic director Tom Jurich (the latter not directly involved in the scandal) on administrative leave, and soon fired both. Further revelations in February 2018 saw more than a dozen additional programs possibly implicated.
Sources: en.wikipedia.org
It is a seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, produced by chemical synthesis rather than extracted from biological tissue. Its design is based on tuftsin, a natural immunomodulatory tetrapeptide. The C-terminal Pro-Gly-Pro segment is a common stabilising motif in short regulatory peptides.
The core four residues correspond to tuftsin, which occurs naturally as part of immunoglobulin G. The full seven-residue sequence, however, is not a known endogenous peptide. It is a laboratory-designed analogue intended to combine tuftsin-like activity with greater resistance to breakdown.
No single receptor has been confirmed as the primary target. Reports describe involvement of the GABAergic system, interference with enkephalin degradation, and shifts in neurotrophic factor expression. Because these observations come from different models and assays, they have not yet been integrated into one accepted mechanism.
Selank is a synthetic heptapeptide designed as a stabilized analog of the natural tetrapeptide tuftsin. It has been investigated mainly for anxiolytic and cognitive effects. It is not an approved pharmaceutical in most countries.